Axiom Bio
PrivateLast Round
M&A
Nov 11, 2015
Total Funding Raised
$23.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Axiom Bio is a biotechnology company that provides AI-driven predictive models to assess molecular toxicity in drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axiom Bio Comparables
Compare Axiom Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quris AI | 83% | |
| VeriSIM Life | 81% | |
| PredictCan Biotechnologies | 81% |
Axiom Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Nov 11, 2015 | ||||
| Grant | Oct 8, 2013 | ||||
| Series A | Oct 8, 2013 | ||||
| Seed | Dec 24, 2012 | ||||
| Debt | Nov 7, 2012 |
Axiom Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Seed, Series A |
| NIH RADx | Grant |
| Zetta Venture Partners | Seed |
| Elm Street Ventures | Seed, Series A |
| Amplify Partners | Seed |
| Dimension | Seed |
| Vital Venture Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 56% MoM.
- Jul 11, 2026
7 of the top 20 pharmaceutical companies are using their system.
Axiom Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Axiom Bio's valuation, stock price, and market status.
Is Axiom Bio a public or private company?
Axiom Bio is a private company.
What is the current stock price of Axiom Bio?
Axiom Bio is a private company with no public stock price. Caplight tracks Axiom Bio's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Axiom Bio worth (valuation)?
Valuation information for Axiom Bio is not publicly available.
Can I buy Axiom Bio stock?
Axiom Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Axiom Bio's last funding round?
Axiom Bio's most recent funding round was M&A on November 11, 2015.
Who are the main investors in Axiom Bio?
Key investors in Axiom Bio include Amplify Partners.
Will Axiom Bio IPO soon?
No public IPO plans have been announced for Axiom Bio.
How can I track Axiom Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Axiom Bio's secondary market activity and sign up for updates.